Ko, A. H., Kim, K.-P., Siveke, J. T., Lopez, C. D., Lacy, J., O’Reilly, E. M., Macarulla, T., Manji, G. A., Lee, J., Ajani, J., Alsina Maqueda, M., Rha, S.-Y., Lau, J., Al-Sakaff, N., Allen, S., Lu, D., Shemesh, C. S., Gan, X., Cha, E., & Oh, D.-Y. (2023). Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. The Oncologist, 28(6), 553-e472. https://doi.org/10.1093/oncolo/oyad022
Subjects:
Pancreatic Cancer Research and Treatment
(OpenAlex Topic)
Epidemiology and Management of Neuroendocrine Tumors
(OpenAlex Topic)
Role of Fibroblast Activation in Cancer Progression
(OpenAlex Topic)
Adenocarcinoma
(MeSH)
Carcinoma, Pancreatic Ductal
(MeSH)
Pancreatic Neoplasms
(MeSH)
Stomach Neoplasms
(MeSH)
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyad022
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: